In the future, it is expected to carry out more case-control studies with multi-centers, large samples and good homogeneity, in order to more scientifically and accurately evaluate the correlation between PTPN22 gene polymorphism and ITP susceptibility, and provide more reliable evidence for basic research and clinical treatment. Here, PTPN22 is linked to autoimmune thrombocytopenic purpura.